Not Yet RecruitingN/Aketamine

Effect of Esketamine on Perioperative Negative Emotions in Breast Cancer Surgery Patients With Severe Depression

Sponsored by Chinese PLA General Hospital

NCT ID
NCT07374211
Target Enrollment
242 participants
Start Date
2026-01-18
Est. Completion
2027-02-01

About This Study

This project employs a prospective, randomized, controlled, blinded, dual-center study design to investigate the effects of intraoperative esketamine on perioperative anxiety and depression symptoms in patients with severe depression undergoing breast cancer surgery.

Conditions Studied

DepressionAnxietyS-ketamineBreast Cancer

Interventions

  • Esketamine 0.3mg/kg
  • normal saline

Eligibility

Sex:FEMALE
Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

1. Age ≥ 18 years.
2. Scheduled to undergo elective breast cancer resection surgery.
3. American Society of Anesthesiologists (ASA) physical status classification of I-III.
4. Clearly understand and voluntarily agree to participate in the study, and sign the informed consent form.
5. Female patients with severe depressive symptoms (defined as a Hospital Anxiety and Depression Scale-Depression subscale score of ≥15)
6. Anticipated anesthesia duration greater than 90 minutes.

Exclusion Criteria:

1. Patients with significant preoperative abnormalities in cardiac, pulmonary, hepatic, or renal function, or coagulation disorders .
2. Patients taking antipsychotics, antidepressants, or glucocorticoids, or with a history of alcohol abuse or illicit drug use .
3. Patients with an MMSE score \<18, dementia, intellectual disability, or those unable to communicate (e.g., coma, severe dementia, hearing or language impairment) .
4. Patients with a history of psychiatric or neurological disorders (e.g., schizophrenia, epilepsy, Parkinson's disease, or severe myasthenia gravis) .
5. Patients with poorly controlled or untreated hypertension (≥180/110 mmHg) .
6. Patients with elevated intracranial or intraocular pressure.
7. Patients with untreated or inadequately treated hyperthyroidism .
8. Patients with a known allergy to the drugs involved in this study .
9. Patients unable to complete the assessment scales required by this study.
10. Patients who are currently participating in other clinical trials

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

WEIDONG MI
CONTACT
133810829wwdd1962@163.com
Weidong Mi Mi
CONTACT
13381082966wwdd1962@163.com
View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source

Effect of Esketamine on Perioperative Negative Emotions in Breast Cancer Surgery Patients With Severe Depression | Huxley